GGrantIndex
Sort

50,496 grants matching lung cancer

FATIGUE, PAIN, AND SLEEP PROBLEMS DURING RADIATION

$738,615
University Of California San Francisco · R01 · FY2001 · NR

Genetic Epidemiology of Lung Cancer

$738,592
Ann G Schwartz · Wayne State University · R01 · FY2006 · CA

Quantifying cardiovascular calcification at very old age for personalized risk classification

$738,579
Kunihiro Matsushita · Johns Hopkins University · R01 · FY2021 · HL

Integrating Tobacco Treatment into Cancer Care

$738,480
Elyse R Park · Massachusetts General Hospital · R01 · FY2012 · CA

(3 of 3) MMC, VICC & TSU: Partners in Eliminating Cancer Disparities

$738,414
Margaret M Whalen · Tennessee State University · U54 · FY2024 · CA

New Therapies to Restore Vascular Integrity During Sepsis

$738,388
Shannon J Odelberg · University Of Utah · R01 · FY2019 · HL

New Therapies to Restore Vascular Integrity During Sepsis

$738,388
Shannon J Odelberg · University Of Utah · R01 · FY2020 · HL

Combination host-directed and antibacterial therapy for pulmonary intracellular infections

$738,160
Patrick S. Stayton · University Of Washington · R01 · FY2024 · AI

Complex 3-Dimensional in vitro Human Skin Tissue Models for Scleroderma

$738,102
Joana M Murad · Celdara Medical, Llc · R44 · FY2019 · AR

Mechanistic Risk Prediction of Radiation Therapy Cardiotoxicity

$738,037
Bonnie Ky · University Of Pennsylvania · R01 · FY2024 · HL

Targeting the chromatin binding domains of BPTF for neuroblastoma epigenetic therapy

$738,024
Marcus Fischer · St. Jude Children'S Research Hospital · R01 · FY2025 · CA

Human Molecular Genetics of Vascular Disease

$737,967
David J. Pinsky · University Of Michigan At Ann Arbor · P30 · FY2009 · HL

Senior Leaders

$737,786
Judith Cheryl Gasson · University Of California Los Angeles · P30 · FY2009 · CA

3D Bioprinted lung cancer models for drug screening

$737,751
Marc Ferrer-Alegre · National Center For Advancing Translational Sciences · ZIA · FY2021 · TR

A systematic approach to uncover the basic mechanisms of checkpoint inhibitor immune related adverse events

$737,672
Adam Mor · Columbia University Health Sciences · R01 · FY2024 · AI

A systematic approach to uncover the basic mechanisms of checkpoint inhibitor immune related adverse events

$737,672
Adam Mor · Columbia University Health Sciences · R01 · FY2023 · AI

Regulation of Lymphocyte Proliferation and Replicative Capacity

$737,535
Richard J. Hodes · Division Of Basic Sciences - Nci · ZIA · FY2011 · CA

BIOMARKER VALIDATION LABORATORIES

$737,284
University Of Alabama At Birmingham · U24 · FY2001 · CA

Colorectal Tumor Risk Prediction in the PLCO Trial

$736,996
Ulrike Peters · Fred Hutchinson Cancer Research Center · U01 · FY2014 · CA

Genetic Susceptibility to Lung Cancer

$736,967
Harvard University (Sch Of Public Hlth) · R01 · FY2005 · CA

Development and Translation of Generator-Produced PET Tracer for Myocardial Perfusion Imaging

$736,765
Vijay Sharma · Washington University · R01 · FY2021 · HL

SurvivorCare: A digital health solution to support long-term cancer survivorship using patient navigation

$736,762
Y. Xian Ho · Dimagi, Inc. · R44 · FY2022 · CA

The VesiVax® System: Vaccine Development Made Easy

$736,747
Samon Ho · Molecular Express, Inc. · R44 · FY2017 · AI

Characterization and Genetics of KI toxicity in iPSC-derived cardiomyocytes

$736,512
Ulrich Broeckel · Medical College Of Wisconsin · R01 · FY2021 · HL

Rapid Automated High-Throughput Radiation Biodosimetry

$736,470
David Jonathan Brenner · Columbia University Health Sciences · U19 · FY2019 · AI